Evidence map›Paper›PMID 39068474›Full record

ArticleJournal of nanobiotechnology2024

Repolarizing neutrophils via MnO

Shan Lu, Ze Mi, Peng Liu, Jinsong Ding, Yiran Ma, Jieru Yang, Pengfei Rong, Wenhu Zhou

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Dendritic cell membrane-based DCsLipo@MnOMaterials today. Bio · 2025
    Article
  12. A MnOMaterials today. Bio · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shan Lu *Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
Ze Mi *Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
Peng LiuKey Laboratory of Biological Nanotechnology, NHC. No. 87 Xiangya Road, Changsha, Hunan, 410008, China.
Jinsong DingXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China.
Yiran MaHunan Prize Life Science Research Institute Co., LTD, 229 Guyuan Road, Changsha, Hunan, 410008, China.
Jieru YangXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China. Jieru.changer@gmail.com.
Pengfei RongDepartment of Radiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China. rongpengfei66@163.com.
Wenhu ZhouXiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410013, China. zhouwenhuyaoji@163.com.

Funding

Graduate Independent Exploration and Innovation Project of Central South University 2022ZZTS0247Hunan Provincial Innovation Foundation for Postgraduate CX20220329Key Research and Development Program of Hunan Province of China 2022SK2025National Natural Science Foundation of China 82372072Science and Technology Program of Hunan Province 2021RC3020
6 · The paper itself

Abstract

Engineered Salmonella has emerged as a promising microbial immunotherapy against tumors; however, its clinical effectiveness has encountered limitations. In our investigation, we unveil a non-dose-dependent type of behavior regarding Salmonella's therapeutic impact and reveal the regulatory role of neutrophils in diminishing the efficacy of this. While Salmonella colonization within tumors recruits a substantial neutrophil population, these neutrophils predominantly polarize into the pro-tumor N2 phenotype, elevating PD-L1 expression and fostering an immunosuppressive milieu within the tumor microenvironment. In order to bypass this challenge, we introduce MnO

Indexed as

ImmunotherapyManganese CompoundsMembrane ProteinsMice, Inbred C57BLNanoparticlesNeutrophilsOxidesSalmonellaTumor MicroenvironmentAnimalsCD8-Positive T-LymphocytesCell Line, TumorFemaleHumansMiceNeoplasmsManganese Compoundsmanganese dioxideMembrane ProteinsOxidesSting1 protein, mouseSTING ProteinImmunotherapyMetal oxidesMicrobial therapyNanomedicineTumor therapy

Identifiers

PMID39068474
PMCPMC11282601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.